Phytopharm Share Discussion Threads

[mrsapeslaptop] 07/3/2012 16:51

Glaucoma news should be next month.

I also wouldnt be surprised if someone takes an option over PD prior to the P2 results.

I expect to see us 20p by mid year.

[bla1se] 16/2/2012 17:34

Yep Henderson GI have increased their holding, from memory the original holding was with Gartmore prior to Hendersons taking them over, at face value would suggest the fund has continuing confidence.

[mrsapeslaptop] 16/2/2012 16:04

Interim Management Statement today.

Only news is
- Glaucoma- results now expected in April, not March

- Phytopica (Id forgotten about that). theyve signed a licence for this with a chinese company who are going to do more product development on it.

recruitment for parkinsons on track. 75% recruited now.

and looks like some institution buys still going through :)

[baldeagle5] 14/2/2012 19:14

Mrs - I like your style and I hope you do join us in the millionaires club! ;-)

[mrsapeslaptop] 14/2/2012 19:11

if my techy skills havent abandoned me.

institutional investment increasing.
wave 3 11pence starting. ready to hold awaiting the glaucoma news this quarter.

multi indication strategy. seems to be proven in POC in multiple indications where ther are NO disease moderating strategies.

little free float (mostly IIs).

less than a year to wait.

Good Luck. I expect to be a millionaire by Xmas (as part of a diversified investment strategy. This SUMM, SAR, a tiny bit of SLN, ASM).

Mrs Ape

[madmonkflin] 09/2/2012 22:49

hardly, the cash is already contracted for trials.

[baldeagle5] 09/2/2012 17:56

"Given the valuation"? You really do live upto your name don;t you? They trade at a small premium to cash - there is NO value embedded in the shares for a succesful Phase 2 later this year. We should be at 20-25p now.

[madmonkflin] 09/2/2012 14:27

I'm just impressed at how the price has kept up so far given the valuation. Good luck all.

[mrsapeslaptop] 09/2/2012 10:37

awaiting glaucoma news in Q1. Then we should clear 12p. as evidence build we are effective and have multiple revenue streams. I expect us to be 60p bt end of year. but we will wiggle a bit before then.
we are quite thinly traded though.

[ferdy1] 07/2/2012 11:34

any support at 8p?

[ferdy1] 02/2/2012 08:03

Looks like a great appointment!

[mrsapeslaptop] 27/1/2012 11:36

Report & accounts are out.

Key points.

-Funded until the end of 2013
-Glaucoma results still expected Q1 this year
- Discussions already started with several big pharmas, but SIGNIFICANT deals not expected until after PII complete
- P61. lead compound identified
- Parkinsons Pii stops recruiting in the spring, so seems to be on track
- 70% of the shares are held by 3 shraeholders. hence the low liquidity we see
- and Alzheimers getting a mention again. I suspect they will resurrect this if we get positive PD results (last time they seemed to think the 3 month trial wasnt long enough and it should have been 6)

[madmonkflin] 27/1/2012 09:53

well hope that doesn't mean they won't be making data available for perusal before that. would be nice if someone snapped this up for 20p.

[mrsapeslaptop] 27/1/2012 09:31

rummaging around the mnd website. they are spending the rest of the year analysing the data and understanding the mode of action. with publication in scientific journals later this year.

[madmonkflin] 27/1/2012 09:07

grief - where did you get that info on ALS?

[mrsapeslaptop] 27/1/2012 08:44

4 of the centres for Parkinsons have stopped recruiting new candidates. looks like we are on track for results later this year.

on the negative side. The full ALS publication of data may not be until the end of the year either.

[mrsapeslaptop] 22/1/2012 11:31

I dont think you will see any BOD buying. I beleive that a licence for ALS is in negotiations. That is why orphan status was organised before the latest data was published. not much longer to wait for that piece of news

[baldeagle5] 21/1/2012 14:24

Madmonk - relax, the chart says it all - a rise to 20p is on the cards.

Just wish the BoD would buy some stock...

[madmonkflin] 20/1/2012 08:58

stock is being sold cheaply even for buys, would have expected the bid to move up on that volume.

[ferdy1] 20/1/2012 08:27

10p today?

[baldeagle5] 19/1/2012 23:37

Get through Phse II later in the year and 50p+ is ours.